Advanced Science (Dec 2023)

Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single‐Cell Transcriptomics

  • Xin Zhang,
  • Boxuan Liang,
  • Yuji Huang,
  • Hao Meng,
  • Zhiming Li,
  • Jiaxin Du,
  • Lang Zhou,
  • Yizhou Zhong,
  • Bo Wang,
  • Xi Lin,
  • Guangchuang Yu,
  • Xuewei Chen,
  • Weixiang Lu,
  • Zhe‐Sheng Chen,
  • Xingfen Yang,
  • Zhenlie Huang

DOI
https://doi.org/10.1002/advs.202303753
Journal volume & issue
Vol. 10, no. 36
pp. n/a – n/a

Abstract

Read online

Abstract The increased use of low‐dose computed tomography screening has led to more frequent detection of early stage lung tumors, including minimally invasive adenocarcinoma (MIA). To unravel the intricacies of tumor cells and the immune microenvironment in MIA, this study performs a comprehensive single‐cell transcriptomic analysis and profiles the transcriptomes of 156,447 cells from fresh paired MIA and invasive adenocarcinoma (IA) tumor samples, peripheral blood mononuclear cells, and adjacent normal tissue samples from three patients with synchronous multiple primary lung adenocarcinoma. This study highlights a connection and heterogeneity between the tumor ecosystem of MIA and IA. MIA tumor cells exhibited high expression of aquaporin‐1 and angiotensin II receptor type 2 and a basal‐like molecular character. Furthermore, it identifies that cathepsin B+ tumor‐associated macrophages may over‐activate CD8+ T cells in MIA, leading to an enrichment of granzyme K+ senescent CD8+ T cells, indicating the possibility of malignant progression behind the indolent appearance of MIA. These findings are further validated in 34 MIA and 35 IA samples by multiplexed immunofluorescence. These findings provide valuable insights into the mechanisms that maintain the indolent nature and prompt tumor progression of MIA and can be used to develop more effective therapeutic targets and strategies for MIA patients.

Keywords